Cargando…

Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression

Aim: Sphingosine 1-phosphate (S1P) has been suggested to be a positive regulator of plasminogen activator inhibitor 1 (PAI-1) in adipocytes, while some studies are not consistent with this prothrombotic property of S1P. Since S1P is bound to apolipoprotein M (apoM) on HDL or to albumin in plasma, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Chiharu, Kurano, Makoto, Nishikawa, Masako, Kano, Kuniyuki, Dohi, Tomotaka, Miyauchi, Katsumi, Daida, Hiroyuki, Shimizu, Tomo, Aoki, Junken, Yatomi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587522/ https://www.ncbi.nlm.nih.gov/pubmed/28321011 http://dx.doi.org/10.5551/jat.37663

Ejemplares similares

Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
por: Kurano, Makoto, et al.
Publicado: (2015)

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes
por: Kurano, Makoto, et al.
Publicado: (2017)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013)

Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
por: Ishimaru, Kazuhiro, et al.
Publicado: (2019)

Lysophospholipids in laboratory medicine
por: YATOMI, Yutaka, et al.
Publicado: (2018)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018)

Analysis of glycero-lysophospholipids in gastric cancerous ascites
por: Emoto, Shigenobu, et al.
Publicado: (2017)

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
por: Kurano, Makoto, et al.
Publicado: (2022)

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate
por: Kobayashi, Tamaki, et al.
Publicado: (2021)

Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay
por: Ohkawa, Ryunosuke, et al.
Publicado: (2018)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021)

Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2019)

Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
por: Sato, Masaya, et al.
Publicado: (2016)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy
por: Kageyama, Yuko, et al.
Publicado: (2020)

Sphingosine 1-Phosphate (S1P) in the Peritoneal Fluid Skews M2 Macrophage and Contributes to the Development of Endometriosis
por: Ono, Yosuke, et al.
Publicado: (2021)

Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022)

Platelet-derived sphingosine 1-phosphate induces migration of Jurkat T cells
por: Iino, Junko, et al.
Publicado: (2014)

Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice
por: Nojiri, Takahiro, et al.
Publicado: (2014)

Light Stress-Induced Increase of Sphingosine 1-Phosphate in Photoreceptors and Its Relevance to Retinal Degeneration
por: Terao, Ryo, et al.
Publicado: (2019)

Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus
por: Kurano, Makoto, et al.
Publicado: (2022)

Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
por: Uranbileg, Baasanjav, et al.
Publicado: (2019)

Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
por: Kurano, Makoto, et al.
Publicado: (2022)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) levels may be associated with lymphoma: An exploratory study with haematological diseases
por: Nishikawa, Masako, et al.
Publicado: (2019)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022)

Measurement of the Spatial Distribution of S1P in Small Quantities of Tissues: Development and Application of a Highly Sensitive LC-MS/MS Method Combined with Laser Microdissection
por: Wang, Jiao, et al.
Publicado: (2019)

Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid
por: Omi, Jumpei, et al.
Publicado: (2021)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model
por: Tando, Yukiko, et al.
Publicado: (2015)

Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects
por: Yukiura, Hiroshi, et al.
Publicado: (2015)

LPP3 localizes LPA(6) signalling to non-contact sites in endothelial cells
por: Yukiura, Hiroshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qnrsp49eduq6cb3mnepcee771m